Efficacy of anifrolumab across organ domains in patients with moderate-to-severe systemic lupus erythematosus: a post-hoc analysis of pooled data from the TULIP-1 and TULIP-2 trials

Autor: Morand, Eric F, Furie, Richard A, Bruce, Ian N, Vital, Edward M, Dall'Era, Maria, Maho, Emmanuelle, Pineda, Lilia, Tummala, Raj *
Zdroj: In The Lancet Rheumatology April 2022 4(4):e282-e292
Databáze: ScienceDirect